Genes Tech Group Holdings Company Limited
Hong Kong Stock ExchangeTotal Valuation
Genes Tech Group Holdings Company Limited carries a market capitalization of 244.00M, placing it among publicly traded companies globally. Its enterprise value stands at 752.10M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 244.00M |
| Enterprise Value | 752.10M |
Share Statistics
Genes Tech Group Holdings Company Limited currently has 1.00B shares outstanding.
| Shares Outstanding | 1.00B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Genes Tech Group Holdings Company Limited trades at a trailing price-to-earnings ratio of 2.95. The price-to-sales ratio is 0.20, and the price-to-book ratio stands at 0.79.
| PE Ratio | 2.95 |
| PS Ratio | 0.20 |
| PB Ratio | 0.79 |
| P/TBV Ratio | 0.37 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Genes Tech Group Holdings Company Limited trades at an EV/EBITDA multiple of 5.39 and an EV/FCF ratio of 53.48. The EV/Sales ratio of 0.56 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 5.39 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.56 |
| EV / EBITDA | 5.39 |
| EV / EBIT | 5.39 |
| EV / FCF | 53.48 |
Financial Position
Genes Tech Group Holdings Company Limited maintains a current ratio of 1.46, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 78.89, indicating elevated leverage, while an interest coverage ratio of 7.12 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.46 |
| Quick Ratio | 0.14 |
| Debt / Equity | 78.89 |
| Debt / EBITDA | 4.56 |
| Interest Coverage | 7.12 |
Financial Efficiency
Genes Tech Group Holdings Company Limited posts a return on equity of 30.05 and a return on invested capital of 6.95.
| Return on Equity (ROE) | 30.05 |
| Return on Assets (ROA) | 3.95 |
| Return on Invested Capital (ROIC) | 6.95 |
| Return on Capital Employed (ROCE) | 10.90 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.86 |
Taxes
Over the trailing twelve months, Genes Tech Group Holdings Company Limited has paid 35.64M in income taxes, reflecting an effective tax rate of 28.23.
| Income Tax | 35.64M |
| Effective Tax Rate | 28.23 |
Stock Price Statistics
Genes Tech Group Holdings Company Limited's stock has gained approximately 253.62319% over the past 52 weeks. The 50-day moving average sits at 0.24, while the 200-day moving average is 0.14.
| Beta (5Y) | N/A |
| 52-Week Price Change | 253.62319% |
| 50-Day Moving Average | 0.24 |
| 200-Day Moving Average | 0.14 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Genes Tech Group Holdings Company Limited generated 1.33B in revenue and converted that into 90.64M in net income, yielding earnings per share of 0.09. EBITDA reached 139.43M, while operating income came in at 139.43M.
| Revenue | 1.33B |
| Gross Profit | 325.96M |
| Operating Income | 139.43M |
| Pretax Income | 126.28M |
| Net Income | 90.64M |
| EBITDA | 139.43M |
| EBIT | 139.43M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
Genes Tech Group Holdings Company Limited holds 150.74M in cash and equivalents against 635.57M in total debt, resulting in a net debt position of 465.80M. Total book value stands at 339.95M, with working capital of 514.03M providing operational flexibility.
| Cash & Cash Equivalents | 150.74M |
| Total Debt | 635.57M |
| Net Debt | 465.80M |
| Equity (Book Value) | 339.95M |
| Book Value Per Share | 0.34 |
| Working Capital | 514.03M |
Margins
Genes Tech Group Holdings Company Limited operates with a gross margin of 24.46, reflecting its pricing power and cost economics. The operating margin of 10.46 and net profit margin of 6.80 provide insight into operational efficiency.
| Gross Margin | 24.46 |
| Operating Margin | 10.46 |
| Pretax Margin | 9.47 |
| Profit Margin | 6.80 |
| EBITDA Margin | 10.46 |
Scores
Genes Tech Group Holdings Company Limited posts an Altman Z-Score of 1.53, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.53 |